Advanced Practice Professional (NP) Adult Inpatient Bone Marrow Stem Cell Transplant and Cellular Therapy and the Outpatient Migration Program

Michigan Medicine is one of the largest health care complexes in the world and has been the site of many groundbreaking medical and technological advancements since the opening of the U-M Medical School in 1850. Michigan Medicine is comprised of over 30,000 employees and our vision is to attract, inspire, and develop outstanding people in medicine, sciences, and healthcare to become one of the world’s most distinguished academic health systems. In some way, great or small, every person here helps to advance this world-class institution. Work at Michigan Medicine and become a victor for the greater good.

Michigan Medicine offers a competitive salary with excellent benefits!

Full Time Salary range:$130,630 - $200,734 / year

What benefits can you look forward to?

• Flexible Health, Dental, and Vision Plans
• Retirement Savings Plans with 2:1 Matching
• Group Term Life Insurance
• Long Term Disability Plan
• Generous Time Off Allowances
• $2200 Annual Professional Development Funds (0.5 FTE Appointment or above)
• Paid Release Time for Professional Education Activities
• Paid Maternity and Parental Leave
• Tuition Support Program(at supervisor discretion/budget)
• Wellness Plans
• Work/Life Resources

• This position will rotate between Adult Inpatient Bone Marrow/Stem Cell Transplantation and Cellular Therapy (BMT/CT) and the Outpatient Migration Program
• Provide care and direct management of adult patients with malignant myeloid and lymphoid hematological disorders with a focus on BMT/CT under a collaborative agreement with BMT physicians and participation with the multidisciplinary team
• Manage complex patients including: performing history/ physical examination and patient evaluation 1-2x/day, orders per Clinical Practice Guideline (CPG) in supportive care treatment regimens, admission of patients, discharges, consults, patient and family education, collaboration and referrals with other health care providers, and provision of education to nursing staff, students, and the community.
• Ability to recognize and appropriately treat: sepsis, chemotherapy toxicities; graft versus host disease (GVHD), cytokine release syndrome (CRS), immune effector cell-associated enterocolitis (IEC-EC), immune effector cell-associated neurotoxicity syndrome (ICANS), cardiac myopathies with arrhythmias, and profound cytopenias requiring daily transfusions.
• Perform procedures such as bone marrow aspiration/biopsy, bone marrow harvest as 2nd assist, lumbar puncture, and skin biopsies for diagnostic and therapeutic indications.
• Review laboratory and radiographic tests results and interface with faculty and patients regarding results and plan of care.
• Participate in clinical trial research through clinically assessing patients and consenting of patients for clinical trial participation as well as participating in clinical trials.
• Facilitate transition of care and function as a liaison between the inpatient and outpatient settings and between staff to ensure continuity of care.
• Participate in workshops and CME activities pertinent to BMT. Attendance at programmatic meetings at Michigan Medicine and occasionally attend regional or national meetings.

NP:

• Current specialty certification to practice as an Adult-Gerontology Acute Care Nurse Practitioner.
• Current specialty certification to practice as a FNP, AGPCNP, or ANP – with 4 years’ experience as an inpatient BMT APP in the similar clinical environment with the same acuity and patient population within the past 6 years.
• Current licensure to practice as a Registered Nurse in the State of Michigan.
• Graduate of an accredited nurse practitioner program.
• Certification as a Nurse Practitioner recognized by the National Council of State Boards of Nursing (NCSBN).
• Current DEA registration required
• AHA Approved BLS
• AHA Approved ACLS
• 1-2 years expertise in the management of acutely ill patients including Telemetry, EKG interpretation and Acute Cardiac Life Support (ACLS) at the Advanced Practice level.
• BMT APP experience required, will consider those with Heme-Onc or Hospitalist experience only.

PA:

• Current license to practice as a Physician Assistant in the State of Michigan.
• Satisfactory completion of a physician assistant program accredited by ARC-PA or one of its predecessor agencies.
• Certification by the National Commission on Certification for Physician Assistants (NCCPA).
• State of Michigan Controlled Substance License Required
• Current DEA registration required
• AHA Approved BLS
• AHA Approved ACLS
• 1-2 years expertise in the management of acutely ill patients including Telemetry, EKG interpretation and Acute Cardiac Life Support (ACLS) at the Advanced Practice level.
• BMT APP experience required, will consider those with Heme-Onc or Hospitalist experience only.

NOTE:

*Employment is contingent upon successful completion of the credentialing and privileging process.
In order to be considered for this position the applicant must have met or will have met all the required qualifications prior to the start date of employment.

RESUME REQUIRED (for both internal & external applicants):
You must attach a complete and accurate resume to be fully considered for this position.

• Clinical experience in cellular and gene therapy as an APP is highly desired.
• Excellent communication and interpersonal skills as measured by references and interviews.
• Demonstrated ability to work effectively in a team environment.
• Ability to work independently with minimal supervision.
• Commitment to clinical and translational research.
• The ability to function independently.
• Demonstrated leadership in work setting and other professional activities.

Employment is contingent upon successful completion of the credentialing and privileging process.

Shift: Day Shift with weekend coverage
Hours: 28 hrs a week
Location: Children’s and Women’s Hospital (C&W), C&W Infusion, University Hospital (UH) with additional sites determined with Cellular and Gene Therapy Program expansion.